Vaccination against SARS-CoV-2

Due to numerous enquiries on the topic of "Vaccination against SARS-CoV-2", we would like to provide you with some information at this point, which comes from the current statement of our professional society, the German Society for Rheumatology (DGRh): 
 

"...All vaccines against SARS-CoV-2 that are currently licensed are non-live vaccines. These "non-live vaccines" can be used without restriction in patients with inflammatory rheumatic diseases and in patients under immunosuppressive/immunomodulatory therapy....
 

Based on the data of the SARS-CoV-2 vaccines available in Germany, there is currently no preference for one SARS-CoV-2 vaccine over another. Therefore, patients with inflammatory rheumatic diseases should receive any available vaccine..." Link to full text.

​

On 28 October 2021 the STIKO recommended to booster all patients with autoimmune diseases and patients with immunosuppressive DMARD therapy or steroid treatment 6 month after their last vaccination.

Detailed information you can find here.

 

In addition, you can also watch an explanatory video on the topic on the DGRh website.

For further information on Covid 19 in patients with rheumatic diseases click here.
 

For detailed information on the topic, we also refer to the pages of the Robert Koch Institute (RKI), which are also constantly updated due to the dynamics of events. If you have a reasonable suspicion of a COVID-19 infection, please continue to contact the competent authorities: GP or the hotlines of the Association of Statutory Health Insurance Physicians (Tel: 116117).

 

We wish you patience and good health during this difficult time.
Your practice team (as of 12.07.21)